HOME >> BIOLOGY >> NEWS
Kansas, Missouri School Board members to explore improvements in science-related education

Nearly 100 elected school board members from three dozen districts in Kansas and Missouri will meet with some of the nations top education experts in Kansas City on Saturday (June 23) to explore how local boards can help to support and improve science, mathematics and technology education from kindergarten through high school.

The Kansas City seminar is the latest phase in an historic three-year national project that is developing plans and materials to help school boards nationwide develop policies and public support for state-of-the-art science, mathematics, and technology curricula. The project is co-sponsored by the American Association for the Advancement of Science (AAAS) and the National School Boards Association (NSBA), with funding provided by the Kansas City-based Ewing Marion Kauffman Foundation.

Saturdays seminar is scheduled to run from 9 a.m. until 5 p.m. at The Westin Crown Center, 1 Pershing Rd., Kansas City, Mo.

The presentations and discussions at the seminar will cover a range of critical issues and challenges in K-12 science, technology and mathematics education. The seminar also will consider public attitudes about science, mathematics, and technology education; performance standards and science literacy; and how school boards can effectively engage the public on controversial science-related issues. The day will conclude with a session devoted to helping board members integrate what they've learned into a preliminary action plan tailored to their individual districts.

Among the speakers: Jo Ellen Roseman, director of AAASs pioneering Project 2061 science literacy initiative; Joseph S. Villani, NSBAs deputy executive director; Will Friedman, director of Public Agendas Center for Advances in Public Engagement; Connie Bertka, director of the AAAS Program of Dialogue on Science, Education and Religion; and Rita Barger, assistant professor of Curriculum & Instructional Leadership at the University of Miss
'"/>

Contact: Edward Lempinen
elempine@aaas.org
925-945-1937
American Association for the Advancement of Science
21-Jun-2007


Page: 1 2

Related biology news :

1. MU researchers to study the status of black bears in Missouri
2. Missouris African-American mothers more likely to deliver prematurely
3. Missouri genetic disorders roots untangled by international team
4. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
5. University of Pittsburgh School of Medicine researchers develop off-the-shelf vascular grafts
6. Johns Hopkins Bloomberg School of Public Health, Geisinger launch new environmental research group
7. Case Western Reserve University School of Medicine researchers awarded $27M for TB research
8. Vitamin extends life in yeast, Dartmouth Medical School researchers find
9. AAAS, National School Boards Asso. join in historic effort to improve science, math & tech education
10. NJIT receives NSF grant to improve math, science and technology education in Newark High Schools
11. NIH Nanomedicine Center draws on NYU School of Medicine expertise

Post Your Comments:
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... Profile Solutions, Inc. (OTC: PSIQ), a leading ... pleased to announce that Dr Gerry Bedore ... of its scientific advisory board. ... leader in technology-enhanced learning models. He was a co-founder ... studies and books focused on online student success and ...
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... NOVATO, Calif. , May 21, 2015 /PRNewswire-USNewswire/ ... Orrin Hatch (R-UT) and Amy ... Product Extensions Now Accelerating Cures & Treatments, or ... 150 rare disease patient advocacy organizations, this bipartisan ... effective, and affordable medicines to rare disease patients ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/84975r/2015_global ... "2015 Global Survey on Flow Cytometry Adoption Trends" ... primary goal of this research is to analyze ... Key information the survey seeks to collect include ... predominantly used applications for flow cytometers, respondents, most ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: